APA (7th ed.) Citation

MD, M., S, G., N, A., R, S., T, P., R, P., . . . DR, S. (2019). A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors. The oncologist, 24(9), 1151. https://doi.org/10.1634/theoncologist.2018-0749

Chicago Style (17th ed.) Citation

MD, Michaelson, et al. "A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors." The Oncologist 24, no. 9 (2019): 1151. https://doi.org/10.1634/theoncologist.2018-0749.

MLA (9th ed.) Citation

MD, Michaelson, et al. "A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors." The Oncologist, vol. 24, no. 9, 2019, p. 1151, https://doi.org/10.1634/theoncologist.2018-0749.